Sol-Gel Technologies Ltd.
IPO- Business Model
- B2B
- Website
- sol-gel.com
- Last Round
- Seed
- Rounds
- 2
- Type
- Public
About
Dermatology company developing advanced treatments for patients with rare skin conditions.
Summary
Sol-Gel Technologies Ltd. is a Biotech company. Investors include Squadron Capital, Great Point Partners and Affinity Asset Advisors.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2026
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...